Amgen Financial Ratios
AMGN / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
89.1%
ROE ranks in the top 25% among Health Care companies
Profit Margin
21.0%
Net Income / Revenue
Asset Turnover
0.41
Revenue / Total Assets
Equity Multiplier
10.46
Total Assets / Equity
Composite: 89.1% (reported: 89.1%)
Profitability
Liquidity
Current Ratio
1.14
Quick Ratio
0.90
Solvency
Interest Coverage
3.61
Efficiency
Asset Turnover
0.41
Inventory Turnover
1.93
Days Sales Outstanding
95 days
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-2.5%
+5.6pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.